Matches in Wikidata for { <http://www.wikidata.org/entity/Q67129881> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q67129881 description "clinical trial" @default.
- Q67129881 description "ensayu clínicu" @default.
- Q67129881 description "klinisch onderzoek" @default.
- Q67129881 description "клінічне випробування" @default.
- Q67129881 name "Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)" @default.
- Q67129881 name "Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis" @default.
- Q67129881 type Item @default.
- Q67129881 label "Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)" @default.
- Q67129881 label "Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis" @default.
- Q67129881 prefLabel "Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)" @default.
- Q67129881 prefLabel "Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis" @default.
- Q67129881 P1050 Q67129881-A8FEA09F-4473-4151-9227-6CDFF4E7BB96 @default.
- Q67129881 P1050 Q67129881-CFD88CEF-A79D-4CA4-BB27-AE45CF7E4AEC @default.
- Q67129881 P1132 Q67129881-846A4360-11CA-41C1-8D49-8BED7D6A11AD @default.
- Q67129881 P1476 Q67129881-21A93A97-C2C8-4C0E-B79C-5DADFCB868F5 @default.
- Q67129881 P17 Q67129881-0A176034-5F2F-4EAD-A48A-3DCAB7545D35 @default.
- Q67129881 P17 Q67129881-191516ED-2200-48A7-9F5E-76E42297D38C @default.
- Q67129881 P17 Q67129881-701E252F-89EF-4A81-A4B2-6A5FC42A8F14 @default.
- Q67129881 P17 Q67129881-852BAE34-03D4-47EC-8ECA-93B3C4E0AA67 @default.
- Q67129881 P17 Q67129881-8AE99E93-8417-49E9-9DEE-1E9DA36D2EE3 @default.
- Q67129881 P17 Q67129881-F1B947F0-787A-4BF2-8BCB-AA5BA8AF599B @default.
- Q67129881 P2899 Q67129881-18E8C3C8-CB52-4332-AF7E-512CFA7594A9 @default.
- Q67129881 P3098 Q67129881-11FB941E-DC8A-47DC-9EE2-308C964DEF0B @default.
- Q67129881 P31 Q67129881-3EB28A3C-90C3-4319-B6E2-C2C1F3B41083 @default.
- Q67129881 P4135 Q67129881-A01623CE-FD57-4A24-9E2D-F46B36ED2217 @default.
- Q67129881 P580 Q67129881-9697404D-50BD-452F-A7C3-AFE19206D3A1 @default.
- Q67129881 P582 Q67129881-D0F09BBB-EA12-43B3-92E8-FECC8B6FA772 @default.
- Q67129881 P6099 Q67129881-73D89344-0612-4C50-94AC-A60ECF9E3EDB @default.
- Q67129881 P8363 Q67129881-383EB662-0A43-4626-955B-F10A7D0D9836 @default.
- Q67129881 P1050 Q229256 @default.
- Q67129881 P1050 Q988594 @default.
- Q67129881 P1132 "+765" @default.
- Q67129881 P1476 "An Open-Label Extension Study to Assess the Long-Term Safety and Efficacy of Dupilumab in Patients ≥6 Months to <18 Years of Age With Atopic Dermatitis" @default.
- Q67129881 P17 Q145 @default.
- Q67129881 P17 Q16 @default.
- Q67129881 P17 Q183 @default.
- Q67129881 P17 Q28 @default.
- Q67129881 P17 Q30 @default.
- Q67129881 P17 Q36 @default.
- Q67129881 P2899 "+6" @default.
- Q67129881 P3098 "NCT02612454" @default.
- Q67129881 P31 Q30612 @default.
- Q67129881 P4135 "+17" @default.
- Q67129881 P580 "2015-10-15T00:00:00Z" @default.
- Q67129881 P582 "2023-11-16T00:00:00Z" @default.
- Q67129881 P6099 Q42824827 @default.
- Q67129881 P8363 Q78089383 @default.